Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is investigating intravitreal bevacizumab with and without oral curcumin for diabetic macular edema and macular edema, including reti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • Curcumin (curcumin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Diabetic Macular Edema, Macular Edema | Phase 2, Phase 3 | Status: RECRUITING